Intravitreal Bevacizumab to Treat Acute Central Serous Chorioretinopathy: Short-Term Effect
نویسندگان
چکیده
منابع مشابه
Intravitreal bevacizumab to treat acute central serous chorioretinopathy: short-term effect.
AIMS To report the beneficial effect of intravitreal bevacizumab (Avastin) injection in patients with acute central serous chorioretinopathy. METHODS Ten eyes of 10 patients with acute central serous chorioretinopathy received an intravitreal bevacizumab (1.25 mg/0.05 ml) injection. At baseline and follow-up visits patients had best corrected visual acuity (BCVA), IOP assessment, dilated fund...
متن کاملIntravitreal bevacizumab in central serous chorioretinopathy.
OBJECTIVE To evaluate the effect of intravitreal bevacizumab injection in patients with central serous chorioretinopathy (CSCR). STUDY DESIGN Quasi-experimental study. PLACE AND DURATION OF STUDY Layton Rehmatullah Benevolent Trust Eye and Cancer Hospital, Lahore, from July 2010 to April 2011. METHODOLOGY There were 43 eyes of 32 adult patients with CSCR. Patients with choroidal neovascul...
متن کاملShort-term efficacy of intravitreal dobesilate in central serous chorioretinopathy
PURPOSE To report the anatomic and functional outcome of intravitreal dobesilate to treat recurrent central serous chorioretinopathy (CSC). METHODS This is an interventional case report in which dobesilate was intravitreally injected in a case of recurrent CSC. Main measures included fundoscopy, Snellen visual acuity (VA) testing, fluorescein angiography and optical coherence tomography (OCT)...
متن کاملThe Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy
PURPOSE To evaluate the effect of intravitreal bevacizumab injection (IVBI) in acute central serous chorioretinopathy (CSC) patients. METHODS Patients with acute CSC received IVBI (1.25 mg/0.05 mL) or observation by randomization. Twelve eyes in each group completed 6 months of regular follow-up and were ultimately included in this study. Each patient was assessed using best corrected visual ...
متن کاملIntravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy
We present a long followed up case of acute central serous chorioretinopathy (CSC) complicated by a severe visual loss due to massive pigment epithelium detachment of the macula after a full-dose photodynamic therapy (PDT). Rapid anatomical and functional improvement was observed after a single intravitreal injection of bevacizumab. To our knowledge, we report the first case of PDT-treated CSC ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Ophthalmologica
سال: 2009
ISSN: 1423-0267,0030-3755
DOI: 10.1159/000224782